Vanda Pharmaceuticals CEO Dr. Mihael Polymeropoulos joins ‘Mornings with Maria’ to discuss Vanda’s recent groundbreaking FDA approvals, including its new oral therapy Nerius to prevent motion sickness and alleviate GLP-1 weight loss medication side effects. Polymeropoulos also breaks news on Vanda’s upcoming direct-to-consumer drug launch and details their landmark legal win over jet lag treatment.
0:00 – FDA Approval for New Motion Sickness Therapy
1:05 – The Need for FDA Reform and Speedier Innovation
1:44 – Solving the GLP-1 “Vomiting” Side Effect
3:27 – Lowering Drug Costs via Direct-to-Consumer Sales
4:20 – Scaling Up: Bipolar I and Schizophrenia Approvals
6:33 – Landmark Legal Win: The Jet Lag Disorder Hearing
Subscribe to Fox Business: https://bit.ly/2D9Cdse
Watch more Fox Business Video: https://video.foxbusiness.com
Watch Fox Business Network Live: http://www.foxnewsgo.com/
FOX Business Network (FBN) is a financial news channel delivering real-time information across all platforms that impact both Main Street and Wall Street. Headquartered in New York — the business capital of the world — FBN launched in October 2007 and is one of the leading business networks on television. In 2025 it opened the year posting double-digit advantages across business day, market hours and total day viewers in January. Additionally, the network continued to lead business news programming, with each business day program placing among the top 15 shows, while FBN delivered its highest-rated month since April 2023 with market hours.
Follow Fox Business on Facebook: https://www.facebook.com/FoxBusiness
Follow Fox Business on Twitter: https://twitter.com/foxbusiness
Follow Fox Business on Instagram: https://www.instagram.com/foxbusiness
